Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +1.09% |
|
+13.50% | -88.47% |
07-09 | JPMorgan Downgrades HilleVax to Neutral From Overweight, Cuts Price Target to $5 From $24 | MT |
07-09 | Guggenheim Downgrades HilleVax to Neutral From Buy, | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.47% | 86.88M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- Leerink Partners Downgrades HilleVax to Market Perform From Outperform, Adjusts Price Target to $2 From $28